Goldman Sachs’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $960K | Buy |
|
|||||
|
2025
Q1 | $894K | Sell |
|
|||||
|
2024
Q4 | $1.72M | Sell |
|
|||||
|
2024
Q3 | $2.93M | Buy |
|
|||||
|
2024
Q2 | $1.68M | Sell |
|
|||||
|
2024
Q1 | $5.94M | Sell |
|
|||||
|
2023
Q4 | $2.71M | Buy |
|
|||||
|
2023
Q3 | $2.12M | Sell |
|
|||||
|
2023
Q2 | $2.73M | Buy |
|
|||||
|
2023
Q1 | $956K | Sell |
|
|||||
|
2022
Q4 | $1.55M | Buy |
|
|||||
|
2022
Q3 | $2.64M | Buy |
|
|||||
|
2022
Q2 | $2.3M | Buy |
|
|||||
|
2022
Q1 | $1.5M | Sell |
|
|||||
|
2021
Q4 | $3.52M | Sell |
|
|||||
|
2021
Q3 | $23.2M | Sell |
|
|||||
|
2021
Q2 | $27.7M | Buy |
|
|||||
|
2021
Q1 | $24.7M | Sell |
|
|||||
|
2020
Q4 | $42.6M | Buy |
|
|||||
|
2020
Q3 | $27.9M | Buy |
|
|||||
|
2020
Q2 | $25.1M | Buy |
|
|||||
|
2020
Q1 | $12.9M | Sell |
|
|||||
|
2019
Q4 | $18M | Buy |
|
|||||
|
2019
Q3 | $6.84M | Buy |
|
|||||
|
2019
Q2 | $5.17M | Buy |
|
|||||
|
2019
Q1 | $5.89M | Sell |
|
|||||
|
2018
Q4 | $4.84M | Sell |
|
|||||
|
2018
Q3 | $8.27M | Buy |
|